Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
2000000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions)
発行・処分する株式数2,000,000Shares
Number of shares delivered during the month: 2,000,000 new shares; treasury shares transferred: None
発行済株式総数
Approximately 1.4% based on 2,000,000 shares delivered during the month and 145,416,193 issued shares as of the end of the month preceding the target month (the disclosure does not describe this as a dilution rate)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
27 May 2026: ¥34.2. Details of the exercise price adjustment provisions are not disclosed in this filing.
Number of Stock Acquisition Rights
Total issued: 210,000; exercised during the month: 20,000; unexercised as of the end of the month preceding the target month: 91,600; unexercised as of the end of the target month: 71,600
Procedures under the Corporate Code of Conduct
Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
Issued on 13 April 2026: Series 16 Stock Acquisition Rights (with exercise price adjustment provisions), Series 17 through Series 19 Stock Acquisition Rights, and the Second Unsecured Straight Bond. The amount is not disclosed in this filing.
| Item | Details |
|---|---|
| Type of issuance or disposal | Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 2,000,000 new shares; treasury shares transferred: None |
| Dilution Rate | Approximately 1.4% based on 2,000,000 shares delivered during the month and 145,416,193 issued shares as of the end of the month preceding the target month (the disclosure does not describe this as a dilution rate) |
| Total number of issued shares | 145,416,193 shares (as of the end of the month preceding the target month) → Not disclosed |
| Exercise price | 27 May 2026: ¥34.2. Details of the exercise price adjustment provisions are not disclosed in this filing. |
| Number of Stock Acquisition Rights | Total issued: 210,000; exercised during the month: 20,000; unexercised as of the end of the month preceding the target month: 91,600; unexercised as of the end of the target month: 71,600 |
| Procedures under the Corporate Code of Conduct | Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Issued on 13 April 2026: Series 16 Stock Acquisition Rights (with exercise price adjustment provisions), Series 17 through Series 19 Stock Acquisition Rights, and the Second Unsecured Straight Bond. The amount is not disclosed in this filing. |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the Series 16 Stock Acquisition Rights.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.